Key performance data can be found in our 2021/22 Annual Report, section 13.
Review our R&D Project Highlights and Therapeutic Areas (TA's).
CSL recognises that donors and their plasma donations are an integral part of helping keep our promise to patients who depend on the life-saving therapies derived from plasma.
We act lawfully, honestly and fairly when competing in the market, and strive to fulfil our responsibilities to shareholders while facilitating access to our therapies for patients.
We aim for direct, open and timely communication with employees, and appropriate consultation on employment matters.
Review a summary of our environmental trends including energy consumption, greenhouse gas (GHG) emissions, and water consumption.
For more information relating to CSL's R&D Project Highlights and Therapeutic Areas (TA's) click the link below.
Popular search terms:
Americas
Asia Pacific
Europe
